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Background
Metformin has been shown to inhibit cell proliferation and
induce cell death in many cancer cell lines. However, some
cell lines exhibit resistance to the cytotoxic effects of met-
formin in tissue culture medium with high glucose levels
(25 mM). Recent studies suggest when glucose is lowered;
metformin becomes increasingly cytotoxic to cancer cells.
However, the precise mechanism for metformin’s cancer
cytotoxicity remains unidentified.
Materials and methods
Cell death assay using Sytox Green Nucleic Acid Stain
Sytox Green nucleic acid stain (10 μM) was added directly
to cells in 96 well plates and read to obtain dead cells.
Total cell number was obtained after adding 0.4% Triton
X-100.
ATP assay 10 μl lysate of equal numbers of cells was
used following the manufacturer’s protocol for ATP assays
from Invitrogen (ATP Determination Kit, A22066).
Lactate Assay Medium was tested for lactate concentra-
tion using L-Lactate Assay Kit (Eton Biosciences Inc.).
Relative lactate level was obtained after normalized by
total cell number.
Measurement of Extra Cellular Acidification Rate
(ECAR) and Oxygen Consumption Rate (OCR) ECAR and
OCR were measured using a Seahorse XF24 analyzer
according to manufacturer’s instructions (Seahorse
Bioscience). ECAR and OCR were plotted after normaliz-
ing to total cell number.
Results
Metformin became more cytotoxic in all of the tested
breast cancer cell lines when glucose concentration was
titrated to low levels in tissue culture medium. Metfor-
min enhanced cytotoxicity in low glucose medium was
correlated with significant reduction of ATP that was
not observed in high glucose containing medium. Sup-
plementing low glucose medium with fructose or galac-
tose failed to prevent the reduction of ATP or to rescue
the cells from metformin induced cell death. This sug-
gested that metformin treated breast cancer cells cannot
efficiently use fructose or galactose to maintain ATP.
Metformin is known to inhibit complex I and prevent
ATP production. However, in high glucose containing
medium metformin treated cells maintained ATP levels
via feedback activation of glycolysis. This enhanced gly-
colysis was either diminished or blocked when metfor-
min treated cells were switched to low glucose, high
fructose or high galactose medium. These findings sug-
gest that lowering glucose potentiates metformin
induced cell death by reducing metformin stimulated
glycolysis.
Conclusions
Our data support a model in which metformin treat-
ment of cancer cells in low glucose medium leads to
cell death by decreasing ATP production via diminishing
or preventing metformin stimulated glycolysis.
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